OPALINSKI Isabelle

Investigador CNRS

Equipo

Organic Synthesis

Grupo: Programadas Molecular Systems

Líneas de Investigación

– Estudio de los sistemas moleculares programado para vectorizar agentes terapéuticos.

– Estudio de las moléculas que reaccionan espontáneamente entrelazado

Contacto

IC2MP
Equipe «Synthèse»
Anexo B27 bâtiment
Université de Poitiers
4 rue Michel Brunet
86022 Poitiers
Tel: +33 (0) 5 49 45 35 18
Email : isabelle.opalinski[at]univ-poitiers.fr

Palabras del producto

vectorización, immolables auto-espaciadores, dendrímeros. glicosidasas, ciclodextrinas, rotaxanos.

Principales publicaciones

VIP Article – “The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumours in Prodrug Monotherapy.” T. Legigan, J. Clarhaut, I. Tranoy-Opalinski, A. Monvoisin, B. Renoux, M. Thomas, A. Lepape, S. Lerondel and S. Papot Angewandte Chemie International Edition, 2012, 51 (46), 11606-11610. (Inside Cover)

“A Galactosidase-Responsive “Trojan Horse” for the Selective Targeting of Folate Receptor-Positive Tumor Cells” M. Thomas, J. Clarhaut, P.-O. Strale, I. Tranoy-Opalinski, Joëlle Roche and S. Papot ChemMedChem 2011, 6, 1006-1010.

“A Heterodimeric Glucuronide Prodrug for Cancer Tritherapy: the Double Role of the Chemical Amplifier” M. Grinda, J. Clarhaut, I. Tranoy-Opalinski, B. Renoux, A. Monvoisin, L. Cronier and S. Papot ChemMedChem 2011, 6, 2137-2141. (Inside Cover)

“A self-immolative dendritic glucuronide prodrug of doxorubicin” M. Grinda, J. Clarhaut, B. Renoux, I. Tranoy-Opalinski and S. Papot MedChemComm 2012, 3, 68-70. (“Hot paper”)

“Design of Self-Immolative Linkers for Tumour-Activated Prodrug Therapy” I. Tranoy-Opalinski, A. Fernandes, M. Thomas, J.-P. Gesson and S. Papot Anti-Cancer Agents Med. Chem. 2008, 8, 618-637 (review article).

Recherche

Menu principal

Haut de page